Advances in Molecular Pathophysiology and Targeted Therapy for Cushing’s Disease
Cushing’s disease is caused by autonomous secretion of adrenocorticotropic hormone (ACTH) from corticotroph pituitary neuroendocrine tumors. As a result, excess cortisol production leads to the overt manifestation of the clinical features of Cushing’s syndrome. Severe complications have been reporte...
Main Authors: | Shinobu Takayasu, Kazunori Kageyama, Makoto Daimon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/2/496 |
Similar Items
-
Differential Effects of Fkbp4 and Fkbp5 on Regulation of the <i>Proopiomelanocortin</i> Gene in Murine AtT-20 Corticotroph Cells
by: Kazunori Kageyama, et al.
Published: (2021-05-01) -
Advances in clinical diagnosis of Cushing's disease
by: Bo⁃wen SUN, et al.
Published: (2020-03-01) -
Clinical Study and Systematic Review of Pituitary Microadenomas vs. Macroadenomas in Cushing’s Disease: Does Size Matter?
by: Amit Akirov, et al.
Published: (2022-03-01) -
A Rare Case of Ectopic Adrenocorticotropic Hormone Secretion from Pancreatic Neuroendocrine Tumour Presenting with Cushing Syndrome
by: Soon Liang Lee, et al.
Published: (2022-03-01) -
Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing Disease
by: Amit Akirov, et al.
Published: (2021-03-01)